Evolution Wealth Advisors, LLC 4 D Molecular Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$19.56 - $32.94 $2,836 - $4,776	-145 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$22.73 - $36.04 $4,909 - $7,784	-216 Reduced 59.83%	145 $4,000
Q2 2021 Jul 22, 2021	BUY	$22.2 - $42.29 $1,665 - $3,171	75 Added 26.22%	361 $9,000
Q1 2021 Apr 20, 2021	BUY	$35.94 - $52.67 $10,278 - $15,063	286 New	286 $12,000

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $675M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.